Skip to Content

Eco-Growth Strategies Inc ECGS

Morningstar Rating
$0.15 +0.02 (15.41%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ECGS is trading within a range we consider fairly valued.
Price
$0.15
Fair Value
$9.31
Uncertainty
Extreme
1-Star Price
$7.62
5-Star Price
$8.68
Economic Moat
Mpdb
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ECGS is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.13
Day Range
$0.150.15
52-Week Range
$0.020.52
Bid/Ask
$0.08 / $0.15
Market Cap
$5.28 Mil
Volume/Avg
2,500 / 13,456

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Eco-Growth Strategies Inc is a nutraceutical company developing a variety of CBD-based products specializing in sourcing and extraction of trusted North American hemp. Its products include CBD distillate oil, CBD Isolate, and CBD crude oil. The Company’s subsidiary, XtractionOne Plus offers CBD Industrial extraction services using state-of-the-art liquid CO2 smart extraction equipment in Arizona.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees

Valuation

Metric
ECGS
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
ECGS
Quick Ratio
Current Ratio
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
ECGS
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ATvjjlbwgymQnpcx$70.0 Bil
MKKGY
Merck KGaA ADRWxdwryrlbWjzcrt$68.1 Bil
HLN
Haleon PLC ADRNwlpsvsrZrl$36.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRGlyjmpwrGzptp$14.3 Bil
VTRS
Viatris IncJwsrzwntlLcbz$13.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRKjfbhvcmpZxck$11.9 Bil
CTLT
Catalent IncJprxymrpmRzfygvc$10.1 Bil
PRGO
Perrigo Co PLCBsxzxjkzrHjqr$4.1 Bil
CURLF
Curaleaf Holdings IncKjnbbwwTzmp$3.7 Bil
PBH
Prestige Consumer Healthcare IncCrqzhjjbsCjxhwg$3.4 Bil

Sponsor Center